Gara Jalqabaatti › Burkitt Lymphoma › New Jersey

Qorannoo klinikaalii Burkitt Lymphoma New Jersey keessatti

Qorannoo 8 Burkitt Lymphoma f New Jersey keessatti hirmaatuu jiru.

Magaalota New Jersey keessatti

Takkalaa qorannoo (Ingiliffa)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

366 Days – 46 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Hackensack Meridian Health, Hackensack
Carol G Simon Cancer Center, Morristown

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick

Namoota walitti qabaa jiraSadarkaa 1/2

6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Saint Peter's University Hospital, New Brunswick
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Regional Cancer Care Associates, Hackensack

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Hackensack University Medical Center, Hackensack

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 04-Cam-2025 · NCT03509961

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.